This Week at FDA: FDA’s autism moves, Novartis gets untitled letter over TV ad, and more

This Week at FDA

This Week at FDAFerdous Al-Faruque

Biologics/ biosimilars/ vaccinesGovernment/legislationGuidanceLeadershipMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)